Table 3

Normalized data of NHAC-kn and hMSC on HDM_derm to control at 7 and 14 days
Experimental time NHAC-kn hMSC
CPII/CPII CTR 7 days 2.02 ± 0.31** 0.90 ± 0.02
14 days 2.07 ± 0.28** 0.97 ± 0.02 °
Aggrecan/Aggrecan CTR 7 days 0.92 ± 0.12 1.48 ± 0.04**
14 days 1.58 ± 0.13°° 1.45 ± 0.03
TGF-β1/TGF-β1 CTR 7 days 0.95 ± 0.05 1.44 ± 0.01**
14 days 1.22 ± 0.17 ° 2.76 ± 0.06**,°°

Bonferroni t test (Mean ± SD, n = 8 replicates):

- between NHAC-kn and hMSC within each experimental time: **, p<0.005.

- between experimental times within each primary cell: °, p < 0.05; °°, p<0.005.

Giavaresi et al.

Giavaresi et al. BMC Musculoskeletal Disorders 2013 14:12   doi:10.1186/1471-2474-14-12

Open Data